Literature DB >> 9523363

Prescription of medications by primary care physicians in the light of asthma guidelines.

K I Gourgoulianis1, B Hamos, K Christou, D Rizopoulou, A Efthimiou.   

Abstract

The purpose of this study was the evaluation of the extent of dissemination of asthma guidelines among primary health care physicians in Greece. Sixty-five of 80 primary care physicians (response rate 80.2%) answered a questionnaire about asthma morbidity, manner of choice of treatment and asthma management plans. One out of 12 patients who were examined by a primary care physician suffered from bronchial asthma. Forty-two physicians treated their asthma patients according to the pulmonologist's recommendations, and only 15 prescribed asthma treatment according to asthma guidelines. beta 2-agonist inhalers and theophylline tablets represent 41% of all prescribed medicines in asthma and corticosteroid inhalers 24% of medications. Eight physicians prescribed theophylline as the first and 20 physicians corticosteroid inhalers as the third choice of medication in asthma treatment. Consequently, the prescription of beta 2-agonist inhalers and theophylline tablets seems to be higher than asthma guidelines recommend. Better dissemination of guidelines among specialists and primary health care physicians will hopefully make asthma management optimal.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9523363     DOI: 10.1159/000029222

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  2 in total

1.  Developing primary care review criteria from evidence-based guidelines: coronary heart disease as a model.

Authors:  Allen Hutchinson; Aileen McIntosh; Jeff Anderson; Claire Gilbert; Rosemary Field
Journal:  Br J Gen Pract       Date:  2003-09       Impact factor: 5.386

2.  Assessing the knowledge of bronchial asthma among primary health care physicians in Crete: a pre- and post-test following an educational course.

Authors:  E Rovithis; C Lionis; S E Schiza; D Bouros; A Karokis; I Vlachonikolis; N M Siafakas
Journal:  BMC Med Educ       Date:  2001-08-01       Impact factor: 2.463

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.